Circulating osteogenic precursor cells in heterotopic bone formation

Stem Cells

Volumn 27, Issue 9, 2009, Pages 2209-2219

  Suda, Robin K ^a   Billings, Paul C ^b   Egan, Kevin P ^a   Kim, Jung Hoon ^a   McCarrick Walmsley, Ruth ^b   Glaser, David L ^b   Porter, David L ^a   Shore, Eileen M ^b   Pignolo, Robert J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone marrow transplantation; Fibrodysplasia ossificans progressive; Heterotopic ossification; Mesenchymal progenitor cells

Indexed keywords

ADHERENT CELL; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BONE DEVELOPMENT; BONE MARROW CELL; CELL COUNT; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC CELL; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSSIFICATION; OSSIFYING MYOSITIS;

ADULT; ANIMALS; BONE MARROW TRANSPLANTATION; CELL LINE; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; MIDDLE AGED; MYOSITIS OSSIFICANS; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS;

MURINAE;

EID: 70349883784     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150     Document Type: Article

References (68)

1. Huss R, Lange C, Weissinger EM, Kolb HJTK. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 2000;18:252-260. (Pubitemid 30602272)
2. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004;36:585-597.
3. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, Ikeda Y. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003;74:833-845. (Pubitemid 38040360)
4. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675. (Pubitemid 38268958)
5. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN. Mesenchymal precursor cells in the blood of normal individuals. Arthrit Res 2000;2:477-488. (Pubitemid 32223796)
6. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol 2001;153:1133-1140.
7. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005;352:1959-1966.
8. Rosada C, Justesen J, Melsvik D, Ebbesen P, Kassem M. The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int 2003;72:135-142. (Pubitemid 36919533)
9. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte- derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003;100:2426-2431. (Pubitemid 36297515)
10. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-7562. (Pubitemid 32525636)
11. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998;160:419-425. (Pubitemid 28116757)
12. Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA 1997;94:6307-6312. (Pubitemid 27270680)
13. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
14. Quan TE, Cowper S, Sou-Pan W, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004;36:598-606. (Pubitemid 38316817)
15. Metz CN. Fibrocytes: A unique cell population implicated in wound healing. Cell Mol Life Sci 2003;60:1342-1350.
16. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE. Peripheral blood fibrocytes from burn patients: Identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82:1183-1192. (Pubitemid 35014852)
17. Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 2008;26:165-175. (Pubitemid 351220134)
18. Brown C, Donnelly TM. Heterotopic bone in the eyes of a guinea pig: Osseous choristoma of the ciliary body. Lab Animal (NY) 2002;31:23-25.
19. Kaufmann AF. Bony spicules in the guinea pig lung. Lab Anim Care 1970;20:1002-1003.
20. Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: Risk factors, prevention, and treatment. J Am Acad Orthop Surg 2002;10:409-416.
21. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-1528. (Pubitemid 32226259)
22. Kaplan FS, Shore EM. Progressive osseous heteroplasia. J Bone Miner Res 2000;15:2084-2094.
23. Kaplan FS, Smith RM. Fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res 1997;12:855.
24. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Koster B, Pauli RM, Reardon W, Zaidi SA, Zasloff M, Morhart R, Mundlos S, Groppe J, Shore EM. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 2009;30:379-390.
25. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006;38:525-527.
26. Kaplan FS, Tabas JA, Gannon FH, Finkel G, Hahn GV, Zasloff MA. The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Joint Surg Am 1993;75:220-230. (Pubitemid 23093972)
27. Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan FS, Shanahan CM. Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: Clues to a vascular origin of heterotopic ossification? J Pathol 2003;201:141-148.
28. Fotino M, Merson EJ, Allen FH Jr. Micromethod for rapid separation of lymphocytes from peripheral blood. Ann Clin Lab Sci 1971;1:131-133.
29. Castro-Malaspina H, Gay RE, Jhanwar SC, Hamilton JA, Chiarieri DR, Meyers PA, Gay S, Moore MA. Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood 1982;59:1046-1054.
30. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci USA 1998;95:10614-10619.
31. Glaser DL, Economides AN, Wang L, Liu X, Kimble RDFJP, Wilson JM, Stahl N, Kaplan FS, Shore EM. In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 2003;85:2332-2342.
32. Chao NJ, Chen BJ. Prophylaxis and treatment of acute graft-versus-host disease. Semin Hematol 2006;43:32-41. (Pubitemid 43063333)
33. Porter DL, Connors JM, Van Deerlin VM, Duffy KM, McGarigle C, Saidman SL, Leonard DG, Antin JH. Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies. J Clin Oncol 1999;17:1234. (Pubitemid 29162949)
34. Spruce WE, Forman SJ, Blume KG, Farbstein MJ, Scott EP, Wolf JL, Krance R. Successful second bone marrow transplantation in a patient with myositis ossificans progressiva and aplastic anemia. Am J Pediatr Hematol Oncol 1983;5:337-340.
35. Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 2007;89:347-357. (Pubitemid 46214354)
36. Kan L, Liu Y, McGuire TL, Palila Berger DM, Awatramani RB, Dymecki SM, Kessler JA. Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells 2009;27:150-156.
37. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, Kamiya N, Fukuda T, Mishina Y, Peterson RT, Bloch KD. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 2008;14:1363-1369.
38. Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidmant ADA, Shore EM, Glaser DL, Goldhamer DJ, Kaplan FS. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 2009;91:652-663.
39. Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 1992;89:11740-11744. (Pubitemid 23004719)
40. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF- 1 induction of SDF-1. Nat Med 2004;10:858-864. (Pubitemid 39070860)
41. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-446. (Pubitemid 39071616)
42. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008;13:206-220. (Pubitemid 351318372)
43. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Bone marrow- derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 2007;354:453-458. (Pubitemid 46161345)
44. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by CXCR4/SDF-1 pathway. Stem Cells 2008;26:223-234.
45. Buring K. On the origin of cells in heterotopic bone formation. Clin Orthop Relat Res 1975;110:293-301.
46. Andersson-Sjöland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, Pardo A, Westergren-Thorsson G, Selman M. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008;40:2129-2140.
47. Bucala R. Circulating fibrocytes: Cellular basis for NSF. J Am Coll Radiol 2008;5:36-39.
48. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006;8:145-150.
49. Rodemann HP, Binder A, Burger A, Guven N, Loffler H, Bamberg M. The underlying cellular mechanism of fibrosis. Kidney Int Suppl 1996;54:S32-S36.
50. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 1995;35:83-90.
51. Deschaseaux F, Gindraux F, Saadi R, Obert L, Chalmers D, Herve P. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br J Haematol 2003;122:506-517. (Pubitemid 36951637)
52. Eghbali-Fatourechi GZ, Modder UI, Charatcharoenwitthaya N, Sanyal A, Undale AH, Clowes JA, Tarara JE, Khosla S. Characterization of circulating osteoblast lineage cells in humans. Bone 2007;40:1370-1377. (Pubitemid 46550982)
53. Aiba S, Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol 1997;24:65-69. (Pubitemid 27099860)
54. Aiba S, Tabata N, Ohtani H, Tagami H. CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol 1994;130:593-597. (Pubitemid 24150938)
55. Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 2002;440:128-133. (Pubitemid 34169848)
56. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 2002;440:298-303. (Pubitemid 34230735)
57. Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S, Tomita T, Ochi TJA. Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol 2001;70:413-421. (Pubitemid 32826129)
58. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008;102:77-85.
59. Rodeheffer MS, Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. Cell 2008;135:240-249.
60. Crossno JT Jr., Majka SM, Grazia T, Gill RG, Klemm DJ. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 2006;116:3220-3228. (Pubitemid 44878636)
61. Koh YJ, Kang S, Lee HJ, Choi TS, Lee HS, Cho CH, Koh GY. Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J Clin Invest 2007;117:3684-3695. (Pubitemid 350224080)
62. Kaplan FS, Groppe J, Pignolo RJ, Shore EM. Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci 2007;1116:113-133. (Pubitemid 350274331)
63. Neal B, Gray H, MacMahon S, Dunn L. Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg 2002;72:808-821. (Pubitemid 35370622)
64. Neal B. Effects of heterotopic bone formation on outcome after hip arthroplasty. ANZ J Surg 2003;73:422-426. (Pubitemid 36897824)
65. Schneider DJ, Moulton MJ, Singapuri K, Chinchilli V, Deol GS, Krenitsky G, Pellegrini VD Jr. The Frank Stinchfield Award. Inhibition of heterotopic ossification with radiation therapy in an animal model. Clin Orthop Relat Res 1998;355:35-46.
66. Ritter MA, Vaughan RB. Ectopic ossification after total hip replacement. J Bone Joint Surg Am 1977;59:345-351.
67. Gössl M, Modder UI, Atkinson EJ, Lerman A, Khosla S. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 2008;52:1314-1325.
68. McGonagle D, Gibbon W, O'Connor P, Blythe D, Wakefield R, Green M, Veale D, Emery P. A preliminary study of ultrasound aspiration of bone erosion in early rheumatoid arthritis. Rheumatology (Oxford) 1999;38:329-331. (Pubitemid 29507182)